Clinical trial · Observational
The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study
The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: A Single Center Retrospective Analysis
NCT05617352CI-TRIAL-00062286completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To clarify the effect of Two-field or Three-field Lymphadenectomy on the survival of esophageal squamous cell carcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Since the data were collected retrospectively, there were no interventions | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- 2F Group
- description
- Patients with Two-field Lymphadenectomy
- interventionNames
- Diagnostic Test: Since the data were collected retrospectively, there were no interventions
- label
- 3F Group
- description
- Patients with Three-field Lymphadenectomy
- interventionNames
- Diagnostic Test: Since the data were collected retrospectively, there were no interventions
Primary outcomes (1)
- measure
- The number of lymph nodes
- timeFrame
- 2010.1.1-2017.12.30
- description
- Surgical data were retrospectively collected
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * 1\. Men and women aged 18-85 years * 2\. Histologically confirmed primary thoracic esophageal squamous cell carcinoma, * 3\. Staging PT1b-4A, N0-3, M0 AJCC eighth edition * 4\. Excluding lymph node dissection \< 15, (meeting the guideline criteria) * 5\. The tumor located in the lower middle thoracic. Exclusion Criteria: * 1\. Patients with a history of previous thoracic and abdominal surgery that may affect lymphatic reflux * 2\. Patients with distant metastasis confirmed by imaging * 3\. Patients with obvious surgical contraindications.
References
Publications (0)
Data not yet available
No reference posted for this study.